Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.
D000328:Adult; D000368:Aged; D000818:Animals; D001681:Biological Assay; D001774:Blood Chemical Analysis / Q000379:methods; D001798:Blood Proteins / Q000276:immunology* / Q000302:isolation & purification; D005591:Chemical Fractionation; D002848:Chromatography, DEAE-Cellulose; D002852:Chromatography, Ion Exchange; D046508:Culture Techniques; D004247:DNA / Q000096:biosynthesis; D005260:Female; D006462:Hemolytic Plaque Technique; D006801:Humans; D006967:Hypersensitivity / Q000150:complications*; D006968:Hypersensitivity, Delayed; D007165:Immunosuppression Therapy; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D051379:Mice; D008875:Middle Aged; D008970:Molecular Weight; D009369:Neoplasms / Q000097:blood / Q000276:immunology*; D010455:Peptides / Q000097:blood / Q000276:immunology* / Q000302:isolation & purification; D012882:Skin Tests
D001798:Blood Proteins; D037102:Lectins; D010455:Peptides; D004247:DNA